The first program studied was Maryland’s statewide quality-based reimbursement program, which is similar to Medicare’s value-based purchasing program. The program involves financial rewards and penalties that aim to foster improvements in process-of-care measures, such as giving aspirin to heart attack patients upon arrival or giving blood-thinning agents to patients after certain surgeries. Because of this program, all clinical process-of-care measures improved by 7.31 percent from 2007 to 2010, compared to the national average of 6.86 percent the study showed.
The study also examined Maryland’s second pay-for-performance program, Maryland Hospital-Acquired Conditions Program, which was rolled out in 2009. The program compared hospitals’ risk-adjusted relative performance on many hospital-acquired conditions. As a result of this program, hospital-acquired conditions declined 15.26 percent in two years, which saved Maryland $110.9 million. If this program was implemented nationally, the Medicare fee-for-service program could have saved $1.3 billion.
Results from both programs show that consistent and clear financial incentives can promote care quality and improve efficiency of care in hospitals, according to the study.
More Articles on Pay-for-Performance:
Blue Cross Blue Shield, Essentia Health Sign Cost Control Agreement
Keystone Mercy Health Plan, Cardiology Group Sign Pay-for-Performance Agreement
Bridging the Gap: 5 Resources on the Transition to Value-Based Care
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
